IL6 and hyperlipidemia: From the point of view of inflammation, pro-inflammatory genes Tumor Necrosis Factor-α (TNF-α) and Interleukin-6 (IL-6) have been reported to be expressed at high levels and contribute to cardiac damage in hyperlipidemia, in addition to canonical inflammatory markers, such as IL-18 and IL-1β [70].